Role of Dietary Sphingolipids and Inhibitors of Sphingolipid Metabolism in Cancer and Other Diseases
Authors:
- Alfred H. MerrillAMAlfred H. Merrill
- Eva-Maria SchmelzESEva-Maria Schmelz
- Elaine WangEWElaine Wang
- Joseph J. SchroederJSJoseph J. Schroeder
- Dirck L. DillehayDDDirck L. Dillehay
- Ronald T. RileyRRRonald T. Riley
- 1 June 1995
- journal article
- review article
- Published by Elsevier in The Journal of Nutrition
- Vol. 125, 1677S-1682S
Abstract
Sphingolipids are found in all eukaryotic and some prokaryotic organisms and participate in the regulation of cell growth, differentiation, and diverse cell functions including cell-cell communication, cell-substratum interactions and intracellular signal transduction. Nonetheless, the field of nutrition has given scant attention to these compounds so that little is known about the following fundamental questions: What is the fate of sphingolipids that are consumed in food? Does consumption of dietary sphingolipids affect the behavior of cells in the gastrointestinal tract or other organs? How do other factors in the diet affect sphingolipid metabolism? Several recent findings underscore the importance of these questions, for examples: 1) Sphingolipids are digested throughout the GI tract to ceramide and sphingosine, which are highly bioactive compounds that affect cellular regulatory pathways; 2) addition of sphingomyelin to a standard AIN diet (which is essentially devoid of sphingolipids) reduces the appearance of aberrant colonic crypts, and perhaps the number of tumors, in mice treated with a colon carcinogen; and 3) an enzyme of sphingolipid metabolism has been discovered to be the target of a class of toxic and carcinogenic mycotoxins called fumonisins. Given these recent findings, it is possible that some of the confusion that has arisen regarding the relationships between dietary fat and disease might be due to the lack of consideration of the sphingolipids that are also present.Keywords
This publication has 36 references indexed in Scilit:
- Disruption of sphingolipid metabolism and stimulation of DNA synthesis by fumonisin B1. A molecular mechanism for carcinogenesis associated with Fusarium moniliforme.Journal of Biological Chemistry, 1994
- Alteration of Tissue and Serum Sphinganine to Sphingosine Ratio: An Early Biomarker of Exposure to Fumonisin-Containing Feeds in PigsToxicology and Applied Pharmacology, 1993
- Fumonisin inhibition of de Novo sphingolipid biosynthesis and cytotoxicity are correlated in LLC-PK1 cellsToxicology and Applied Pharmacology, 1992
- Influences of sphingosine on two-stage skin tumorigenesis in Sencar miceCancer Letters, 1992
- Sphingosine inhibits phosphatidate phosphohydrolase in human neutrophils by a protein kinase C-independent mechanismJournal of Biological Chemistry, 1991
- Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon. Specific role in cell differentiation.Journal of Biological Chemistry, 1991
- Primary liver cancer and oesophageal basal cell hyperplasia in rats caused by fusarium moniliformeInternational Journal of Cancer, 1984
- On the chemistry and occurrence of sphingolipid long-chain basesChemistry and Physics of Lipids, 1970
- Metabolism of cerebroside in the intestinal tract of the ratBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1969
- Metabolism of sphingomyelin in the intestinal tract of the ratBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1968